Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sarah Tettamanti, Maria Caterina Rotiroti, Greta Maria Paola Giordano Attianese, Silvia Arcangeli, Ronghua Zhang, Priyanka Banerjee, Giovanni Galletti, Sheighlah McManus, Massimiliano Mazza, Fabio Nicolini, Giovanni Martinelli, Cristina Ivan, Tania Veliz Rodriguez, Federica Barbaglio, Lydia Scarfò, Maurilio Ponzoni, William Wierda, Varsha Gandhi, Michael Keating, Andrea Biondi, Federico Caligaris-Cappio, Ettore Biagi, Paolo Ghia & Maria Teresa Sabrina Bertilaccio. (2022) Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia. Leukemia & Lymphoma 63:7, pages 1566-1579.
Read now
Read now
Yue Zhou, Ai-Qing Nie, Shang Chen, Meng-Meng Wang, Rui Yin, Bo-Hao Tang, Yue-E Wu, Fan Yang, Bin Du, Hai-Yan Shi, Xin-Mei Yang, Guo-Xiang Hao, Xiu-Li Guo, Qiu-Ju Han, Yi Zheng & Wei Zhao. (2021) Downregulation of Renal MRPs Transporters in Acute Lymphoblastic Leukemia Mediated by the IL-6/STAT3/PXR Signaling Pathway. Journal of Inflammation Research 14, pages 2239-2252.
Read now
Read now
Marcin Kubeczko, Elżbieta Nowara, Dobromiła Karwasiecka, Grażyna Siewior, Paulina Czajka-Francuz, Jerzy Chudek & Jerzy Wojnar. (2016) C–C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation. Hematology 21:6, pages 343-350.
Read now
Read now
Bodo E. Lippitz & Robert A. Harris. (2016) Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis . OncoImmunology 5:5.
Read now
Read now
Omar Perbellini, Federica Cioffi, Giorgio Malpeli, Elisabetta Zanolin, Ornella Lovato, Aldo Scarpa, Giovanni Pizzolo & Maria T. Scupoli. (2015) Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia. Leukemia & Lymphoma 56:6, pages 1897-1900.
Read now
Read now
J. Claire Godbersen, Cody Paiva, Olga V. Danilova, Allison Berger, Jennifer R. Brown & Alexey V. Danilov. (2015) Targeting neddylation effectively antagonizes nuclear factor-κB in chronic lymphocytic leukemia B-cells. Leukemia & Lymphoma 56:5, pages 1566-1569.
Read now
Read now
Articles from other publishers (30)
Rui Hu, Xiaosui Ling, Tonghua Yang, Jinping Zhang, Xuezhong Gu, Fan Li, Heng Chen, Yan Wen, Zengzheng Li, Yunlian Zou & Yunyun Du. (2023) Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy. Clinical and Experimental Medicine.
Crossref
Crossref
Natalya Plakhova, Vasilios Panagopoulos, Kate Vandyke, Andrew C. W. Zannettino & Krzysztof M. Mrozik. (2023) Mesenchymal stromal cell senescence in haematological malignancies. Cancer and Metastasis Reviews 42:1, pages 277-296.
Crossref
Crossref
Maryam Khodashenas, Arezoo Rajabian, Armin Attaranzadeh, Fahimeh Lavi Arab, Negin Allahyari & Abolghasem Allahyari. (2022) Evaluation of cytokine levels as possible predicting elements in patients with chronic lymphocytic leukemia. Revista da Associação Médica Brasileira 68:10, pages 1364-1368.
Crossref
Crossref
G. Ishdorj, Z. Nugent, M. Squires, S. Kost, V. Banerji, L. Davidson, C.S. Katyal, A. Marshall, S.B. Gibson & J.B. Johnston. (2021) Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines. Leukemia Research 109, pages 106628.
Crossref
Crossref
Candida Vitale, Elia Boccellato, Lorenzo Comba, Rebecca Jones, Francesca Perutelli, Valentina Griggio & Marta Coscia. (2021) Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia. Cancers 13:15, pages 3856.
Crossref
Crossref
Ivan Dzis, Oleksandra Tomashevska, Yevhen Dzis & Zoryana Korytko. (2020) Prediction of survival in non-Hodgkin lymphoma based on markers of systemic inflammation, anemia, hypercoagulability, dyslipidemia, and Eastern Cooperative Oncology Group performance status. Acta Haematologica Polonica 51:1, pages 34-41.
Crossref
Crossref
Ameen Abdulaziz Basabaeen, Enaam Abdelrhman Abdelgader, Ebtihal Ahmed Babekir, Nada Hassan Eltayeb, Osama Ali Altayeb, Eman Abbass Fadul, Othman Saeed Bahashwan & Ibrahim Khider Ibrahim. (2019) Clinical presentation and hematological profile among young and old chronic lymphocytic leukemia patients in Sudan. BMC Research Notes 12:1.
Crossref
Crossref
Yun ChenLiguang ChenJian YuEmanuela M. GhiaMichael Y. ChoiLing ZhangSuping Zhang, Elsa Sanchez-Lopez, George F. WidhopfIIIIKaren MesserLaura Z. RassentiCatriona Jamieson & Thomas J. Kipps. (2019) Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia. Blood 134:13, pages 1084-1094.
Crossref
Crossref
Ganchimeg IshdorjErin Streu, Pascal Lambert, Harbhajan S. DhaliwalSalaheddin M. MahmudSpencer B. Gibson, Versha BanerjiAaron J. Marshall & James B. Johnston. (2019) IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia. Blood Advances 3:14, pages 2188-2198.
Crossref
Crossref
Lena Schulze-Edinghausen, Claudia Dürr, Selcen Öztürk, Manuela Zucknick, Axel Benner, Verena Kalter, Sibylle Ohl, Viola Close, Patrick Wuchter, Stephan Stilgenbauer, Peter Lichter & Martina Seiffert. (2019) Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia. Cancers 11:6, pages 822.
Crossref
Crossref
Enrique Podaza & Denise Risnik. (2019) Neglected players: Tumor associated neutrophils involvement in chronic lymphocytic leukemia progression. Oncotarget 10:20, pages 1862-1863.
Crossref
Crossref
Masanori Kawano, Kazuhiro Tanaka, Ichiro Itonaga, Tatsuya Iwasaki & Hiroshi Tsumura. (2018) Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment. Cell Communication and Signaling 16:1.
Crossref
Crossref
Kheng Ng, Angelia Sia, Maxel Ng, Crystal Tan, Hui Chan, Chay Tan, Iris Rawtaer, Lei Feng, Rathi Mahendran, Anis Larbi, Ee Kua & Roger Ho. (2018) Effects of Horticultural Therapy on Asian Older Adults: A Randomized Controlled Trial. International Journal of Environmental Research and Public Health 15:8, pages 1705.
Crossref
Crossref
Fang Zhu, Lindsay McCaw, David E. Spaner & Reginald M. Gorczynski. (2018) Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitro. Leukemia Research 66, pages 28-38.
Crossref
Crossref
Wootae Kim, Jaehyuk Pyo, Byeong-Joo Noh, Joo-Won Jeong, Juhie Lee & Ja-Eun Kim. (2017) CCAR2 negatively regulates IL-8 production in cervical cancer cells. Oncotarget 9:1, pages 1143-1155.
Crossref
Crossref
Natalia-Del Pilar Vanegas & Jean-Paul Vernot. (2017) Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche. Experimental Hematology & Oncology 6:1.
Crossref
Crossref
Denise Risnik, Enrique Podaza, María B. Almejún, Ana Colado, Esteban E. Elías, Raimundo F. Bezares, Horacio Fernández-Grecco, Santiago Cranco, Julio C. Sánchez-Ávalos, Mercedes Borge, Romina Gamberale & Mirta Giordano. (2017) Revisiting the role of interleukin-8 in chronic lymphocytic leukemia. Scientific Reports 7:1.
Crossref
Crossref
Thomas Clapes, Stylianos Lefkopoulos & Eirini Trompouki. (2016) Stress and Non-Stress Roles of Inflammatory Signals during HSC Emergence and Maintenance. Frontiers in Immunology 7.
Crossref
Crossref
Yuying LiZhonghua DuXu WangGuanjun WangWei Li. (2016)
Association of
IL-6
Promoter and Receptor Polymorphisms with Multiple Myeloma Risk: A Systematic Review and Meta-Analysis
. Genetic Testing and Molecular Biomarkers 20:10, pages 587-596.
Crossref
Crossref
Carsten U. Niemann, Sarah E.M. Herman, Irina Maric, Julio Gomez-Rodriguez, Angelique Biancotto, Betty Y. Chang, Sabrina Martyr, Maryalice Stetler-Stevenson, Constance M. Yuan, Katherine R. Calvo, Raul C. Braylan, Janet Valdez, Yuh Shan Lee, Deanna H. Wong, Jade Jones, Clare Sun, Gerald E. Marti, Mohammed Z.H. Farooqui & Adrian Wiestner. (2016)
Disruption of
in vivo
Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study
. Clinical Cancer Research 22:7, pages 1572-1582.
Crossref
Crossref
Valentina Trimarco, Elisa Ave, Monica Facco, Giorgia Chiodin, Federica Frezzato, Veronica Martini, Cristina Gattazzo, Federica Lessi, Carlo Alberto Giorgi, Andrea Visentin, Monica Castelli, Filippo Severin, Renato Zambello, Francesco Piazza, Gianpietro Semenzato & Livio Trentin. (2015) Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival. Oncotarget 6:39, pages 42130-42149.
Crossref
Crossref
Yanmei LiYonghong ShiLindsay McCawYou-Jun LiFang ZhuReg GorczynskiGordon S. DuncanBurton YangYaacov Ben-David & David E. Spaner. (2015) Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A. Blood 126:6, pages 766-778.
Crossref
Crossref
Kang Lu, Xiao-sheng Fang, Li-li Feng, Yu-jie Jiang, Xiang-xiang Zhou, Xin Liu, Pei-pei Li, Na Chen, Mei Ding, Na Wang, Jie Zhang & Xin Wang. (2015) The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Cancer Letters 359:2, pages 250-258.
Crossref
Crossref
Arseniy E. Yuzhalin & Anton G. Kutikhin. 2015. Interleukins in Cancer Biology. Interleukins in Cancer Biology
117
146
.
M Masoodi, E Lee, M Eiden, A Bahlo, Y Shi, R B Ceddia, C Baccei, P Prasit & D E Spaner. (2014) A role for oleoylethanolamide in chronic lymphocytic leukemia. Leukemia 28:7, pages 1381-1387.
Crossref
Crossref
Erin Streu. (2014) Second Malignancies in Chronic Lymphocytic Leukemia. Oncology Nursing Forum 41:1, pages 95-98.
Crossref
Crossref
Sandrine T. Lafarge, James B. Johnston, Spencer B. Gibson & Aaron J. Marshall. (2014) Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway. Leukemia Research 38:1, pages 109-115.
Crossref
Crossref
Uri Rozovski, Michael J. Keating & Zeev Estrov. (2013) Targeting inflammatory pathways in chronic lymphocytic leukemia. Critical Reviews in Oncology/Hematology 88:3, pages 655-666.
Crossref
Crossref
S Beiggi, J B Johnston, M D Seftel, M W Pitz, R Kumar, V Banerji, E J Griffith & S B Gibson. (2013) Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study. British Journal of Cancer 109:5, pages 1287-1290.
Crossref
Crossref
Emilie Laprevotte, Lo?c Ysebaert, Christian Klein, Wilfried Valleron, Amandine Blanc, Emilie Gross, Guy Laurent, Jean-Jacques Fourni?Anne Quillet-Mary. (2013) Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia. Leukemia Research 37:4, pages 440-446.
Crossref
Crossref